Following babies born with congenital CMV infection over time in New York State
Follows infants who screen positive for congenital CMV to learn about their health.
Key facts
- Who runs it
- Stony Brook University
- Where
- Stony Brook, United StatesSee the site
- Trial code
- Registry title
- Long-Term Outcomes of Children With Congenital CMV in New York State
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 1 Feb 2024
- Planned end
- 1 Oct 2026
- Type of study
- Observational, 4 groups
- Record updated
- 13 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for babies born in New York State during the cCMV newborn screening pilot (September 27, 2023 - October 1, 2024). They must have had a CMV screen or test result in one of four groups, and been checked at a designated NYS cCMV clinic.
- Age
- 0 Days to 1 Year
- Sex
- All
- Disease stage
- Four groups can join: CMV found by the newborn screen and confirmed; CMV missed by the screen but confirmed by a later test; positive screen but negative confirmatory test; or premature babies with a late positive screen and confirmed CMV.
- Biomarker or test result
- For premature babies: born before 37 weeks, positive NYS newborn screen collected before 44 weeks gestational age, and positive confirmatory test within 14 days of the positive screen.
Main reasons for not taking part
- Babies whose parents refuse to take part in the long-term follow-up
- Families not willing or able to complete all study steps
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Neonates born in New York State during cCMV NBS Pilot Program (September 27, 2023 - October 1, 2024)
- cCMV evaluation provided by a designated NYS cCMV clinical referral site
- Family willing and able to complete all study procedures
- Study participants meet criteria for one of the following four categories:
- 1. Category 1 (Confirmed cCMV identified by NBS Program): cCMV NYS newborn screen positive AND cCMV confirmatory test positive
- 2. Category 2 (Confirmed cCMV not identified by NBS Program): cCMV NYS newborn screen negative AND cCMV confirmatory test positive
- 3. Category 3 (False-positive cCMV screen): cCMV NYS newborn screen positive AND negative cCMV confirmatory test
- 4. Category 4 (Premature infants with confirmed CMV infection on late positive NBS): Infant born prior to 37 weeks gestation AND cCMV positive on any NYS newborn screen collected prior to 44 weeks gestational age AND Positive cCMV confirmatory test obtained within 14 days of a positive NBS
Who cannot take part
- Neonate whose parents refuse participation in the long-term follow-up study
Where in United States
- Stony Brook Children's HospitalStony Brook, United StatesContact: Andrew Handel, MDTaking people
About the trial
What the trial wants to find out
PROACTIVE NYS is a long-term follow-up study of all infants who test positive for congenital Cytomegalovirus infection (CMV) throughout New York State on the Newborn Screen. By following all infants who screen positive, we will learn important information about the range of symptoms caused by congenital CMV, from those babies with more severe findings to those with no symptoms.
Read full original descriptionShow less
In particular, our study will provide new information about many facets of congenital CMV, including:
* Developmental, hearing, neurologic, and vision outcomes * The spectrum and timing of symptoms * The impact congenital CMV has on the baby and its family * How many babies are infected with congenital CMV in New York State How antiviral medications and other interventions impact outcomes of children with congenital CMV
Throughout the duration of the study, children will undergo routine developmental and hearing assessments, which will assist with early diagnosis of any infection complications.
Any child found to have a neurodevelopmental, hearing, or vision abnormality will be referred for appropriate evaluation and treatment.
Families will also be asked to complete periodic surveys about their experience with congenital CMV, both as a medical diagnosis and as it affects their day-to-day activities.
The 4 groups in the trial
- Category 1: Confirmed cCMV infection identified by NYS newborn screen
Infants who have both a positive cCMV NYS newborn screen AND are positive for cCMV on confirmatory testing
- Category 2: Confirmed cCMV infection NOT identified by NYS newborn screen
Infants who have both a NEGATIVE cCMV NYS newborn screen AND are found to have cCMV on confirmatory testing
- Category 3: False-positive cCMV NYS newborn screen
Infants who have both a positive cCMV NYS newborn screen AND are NEGATIVE for cCMV on confirmatory testing
- Category 4: Premature infants with confirmed CMV infection on late positive NBS
Infants who are: (a) born prior to 37 weeks gestation AND (b) cCMV positive on any NYS newborn screen collected prior to 44 weeks gestational age AND (c) Have a positive cCMV confirmatory test obtained within 14 days of a positive NYS newborn screen
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective Observational Study of Asymptomatic cCMV Transmission to Infants for Virological Evaluation in New York State
- Plain-language title
- Following babies born with congenital CMV infection over time in New York StateGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 13 May 2025